<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Placement of vena cava filters and their complications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Placement of vena cava filters and their complications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Placement of vena cava filters and their complications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter F Fedullo, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne Roberts, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jess Mandel, MD, MACP, ATSF, FRCP</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Vena cava filters can be placed into the inferior vena cava (IVC) or, much less commonly, the superior vena cava (SVC) as a treatment to prevent pulmonary embolism. </p><p>Two general types of vena cava filters are available: permanent and retrievable. When retrievable IVC filters are used, it is important to create a plan for removing the filter as soon as protection is no longer needed.</p><p>IVC filters are typically placed in an interventional suite using fluoroscopy to guide the final position of the filter. Alternatively, IVC filters can be placed at the bedside either using fluoroscopy or transabdominal or intravascular ultrasound. Knowledge of the normal and variant anatomy of the vena cava is important for successful placement of vena cava filters and prevention of complications.</p><p>Complications related to IVC filters can occur at the time of filter placement (technical issues, medication related) or at a later time related to the access site, the filter itself (eg, thrombosis), or as a consequence of filter retrieval.</p><p>The placement and complications associated with predominantly IVC filters are reviewed here. Other treatments for deep venous thrombosis and acute pulmonary embolism are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1335.html" rel="external">"Prevention of venous thromboembolism in adults undergoing hip fracture repair or hip or knee replacement"</a> and  <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">"Treatment, prognosis, and follow-up of acute pulmonary embolism in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8259.html" rel="external">"Approach to thrombolytic (fibrinolytic) therapy in acute pulmonary embolism: Patient selection and administration"</a>.)</p><p class="headingAnchor" id="H5678145"><span class="h1">FILTER UTILIZATION</span><span class="headingEndMark"> — </span>Utilization of IVC filters varies widely [<a href="#rid1">1-6</a>]. Some of the variability may be related to differences in available guidelines and interpretation of these guidelines in various populations: in particular, what constitutes a contraindication to or failure of anticoagulation, and the appropriateness of prophylactic filter placement [<a href="#rid7">7-11</a>]. (See  <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a> and  <a class="medical medical_review" href="/z/d/html/113028.html" rel="external">"Venous thromboembolism risk and prevention in the severely injured trauma patient"</a>.)</p><p>The only widely accepted and validated indications for vena cava filter placement in patients with venous thromboembolism are an absolute contraindication to therapeutic anticoagulation, complications of anticoagulation, and failure of anticoagulation when there is acute proximal venous thrombosis. The effectiveness of filter placement even for these limited indications has been questioned. A retrospective study concluded that use of IVC filters in patients with venous thromboembolism and a contraindication to anticoagulation was associated with a higher 30 day mortality compared with treatment without IVC filter placement [<a href="#rid12">12,13</a>]. Whether or not this finding is true or is related to weaknesses inherent to observational trials, IVC filter effectiveness in patients with VTE remains uncertain in the absence of randomized clinical trials. (See  <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">"Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)", section on 'Inferior vena cava filter'</a>.)</p><p>Other possible treatment indications, and prophylactic filter placement, are even more controversial [<a href="#rid14">14-21</a>]. (See  <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">"Treatment, prognosis, and follow-up of acute pulmonary embolism in adults", section on 'Inferior vena cava filters'</a> and  <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">"Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)", section on 'Supportive therapies'</a> and  <a class="medical medical_review" href="/z/d/html/113028.html" rel="external">"Venous thromboembolism risk and prevention in the severely injured trauma patient"</a>.)</p><p>Nevertheless, with the increasing ease of placement of vena cava filters, including bedside insertion under ultrasonographic guidance, their use has steadily increased [<a href="#rid22">22</a>], and the reported "indications for use" have been extended to include prophylactic filters in patients at high risk for venous thromboembolism, particularly following trauma [<a href="#rid15">15,16,18-20</a>]. In a study of 263 hospitals and 130,643 acute venous thromboembolism hospitalizations, vena cava filter placement occurred in 15 percent overall with high variability ranging from 0 to 39 percent [<a href="#rid3">3</a>]. Significant clinical predictors of vena cava filter use included acute bleeding at the time of admission (odds ratio [OR] 3.4, 95% CI 3.2-3.6), major operation after admission (OR 3.4, 95% CI 3.3-3.5), presence of metastatic cancer (OR 1.7, 95% CI 1.6-1.8), and more severe illness (OR 2.5, 95% CI 2.3-2.7). Hospital characteristics associated with lower vena cava filter use included a small number of beds (&lt;100 versus &gt;400 beds; OR 0.2, 95% CI 0.2-0.4) and rural location (OR 0.4, 95% CI 0.2-0.5). Use varied widely, even in geographically proximate areas. </p><p>For prophylactic filter placement, use also varies widely. Several series have reported that "prophylactic" filter placement is becoming more common than insertion for "therapeutic" purposes [<a href="#rid18">18-20</a>]. In a study from the Nationwide Inpatient Sample (NIS), prophylactic vena cava filter placement increased at a significantly higher rate compared with placement associated with deep vein thrombosis or pulmonary embolus (157 versus 42 percent) over the seven-year study period (1998 to 2005) [<a href="#rid18">18</a>]. Whether a prophylactic filter is placed may also depend on insurance status. In a study of the National Trauma Data Bank, significantly fewer IVC filters were placed in noninsured compared with insured patients (2.7 versus 4.9 percent) [<a href="#rid23">23</a>]. Rising concerns over the increase in prophylactic filter placement, poor retrieval rate, and adverse events prompted warnings from the US Food and Drug Administration in 2010 that were updated in 2014 [<a href="#rid24">24</a>]. Following these warnings, one study showed a decrease in the rate of IVC filter placement (all types) from 55.1 in 2010 to 39.1 in 2014 (per 100,000 US population) [<a href="#rid22">22</a>]. In a retrospective trauma cohort study, regardless of a declining use of IVC filters (&gt;90 percent prophylactic), the rate of pulmonary embolism remained largely unchanged [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H2984873208"><span class="h1">TYPES OF FILTERS</span><span class="headingEndMark"> — </span>Surgical interruption of the inferior vena cava (IVC) to prevent pulmonary embolism (simple ligation, DeWeese clip) was performed with general anesthesia via a retroperitoneal incision until transvenous interruption of the IVC (via direct venous access) became clinically feasible in 1967 [<a href="#rid26">26</a>]. Although vena cava filters can be placed into the superior vena cava in select situations, the IVC is the standard location for filter placement. Since the introduction of the original Greenfield filter, which required a surgical cutdown until a percutaneous approach was later described, a number of percutaneous IVC filters have been developed. IVC filter devices are designed to optimize flow dynamics, maximize clot-trapping capacity, expedite ease of insertion, and, for some filters, allow future retrieval  (<a class="graphic graphic_figure graphicRef69737" href="/z/d/graphic/69737.html" rel="external">figure 1</a>) [<a href="#rid27">27-30</a>]. </p><p class="headingAnchor" id="H798800702"><span class="h2">Nonretrievable filters</span><span class="headingEndMark"> — </span>Several nonretrievable IVC filters are available for use  (<a class="graphic graphic_figure graphicRef69737" href="/z/d/graphic/69737.html" rel="external">figure 1</a>) [<a href="#rid26">26</a>]. Beyond differences in design and material, each differs in terms of the diameter of the introducer system. An important design feature involves the maximal IVC diameter that can be accommodated by the device. Among the currently available filters, most of the permanent filters can only be placed in an IVC with a diameter of 28 mm or less. The TrapEase can be used up to 30 mm, and only the Bird's Nest filter can be placed in a larger IVC up to a diameter of 40 mm. An alternative strategy for patients with an IVC too large to accommodate non-Bird's-Nest filters is the placement of bilateral retrievable filters into each of the common iliac veins [<a href="#rid31">31</a>].</p><p class="headingAnchor" id="H2783832520"><span class="h2">Retrievable filters</span><span class="headingEndMark"> — </span>A number of retrievable (or "optional") filters are also available  (<a class="graphic graphic_figure graphicRef69737" href="/z/d/graphic/69737.html" rel="external">figure 1</a>) [<a href="#rid26">26</a>]. Prophylactic filter placement appears to have no effect on mortality, but its use is associated with an increased risk for deep vein thrombosis and other complications [<a href="#rid6">6,21</a>]. </p><p>The US Food and Drug Administration (FDA) issued an initial warning in 2010 updated in 2014 regarding timely removal of retrievable filters to minimize adverse events, stating that physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters should remove the filter as soon as protection from pulmonary embolism is no longer needed [<a href="#rid24">24,32</a>]. (See <a class="local">'Filter retrieval'</a> below and <a class="local">'Complications'</a> below.)</p><p>Most of the retrievable filters can be placed in an IVC up to 30 mm, but the ALN can be used up to 32 mm and Denali filters can only be placed in an IVC of 28 mm maximum diameter  (<a class="graphic graphic_figure graphicRef69737" href="/z/d/graphic/69737.html" rel="external">figure 1</a>). A novel retrievable IVC filter that is permanently attached to a central venous catheter is available and is inserted via a femoral access [<a href="#rid33">33-36</a>]. As is the case with any central venous catheter, the risk of catheter-associated infection or thrombotic complications should be weighed against the potential benefits of the device.</p><p>Whether retrievable IVC filters are cost effective is unknown. A theoretically based cost analysis that compared retrievable IVC filters placed for prophylactic versus therapeutic indications in high-risk trauma patients found that prophylactic filters were slightly more costly (USD $37,700 versus $37,300) and less effective (quality-adjusted life year [QALY] difference 0.139) in a base case analysis [<a href="#rid37">37</a>]. Prophylactic filter placement would become a preferred strategy for individuals never having a filter, who have either an annual probability of venous thromboembolism ≥9.6 percent (base case, 5.9 percent) or a very high annual probability of anticoagulation complications ≥24.3 percent (base case, 2.5 percent). A prophylactic filter strategy would also be favored for an annual probability of venous insufficiency after filter removal &lt;7.7 percent (base case, 13.9 percent) or &lt;1.90 percent with a retained filter (base case, 14.1 percent). </p><p class="headingAnchor" id="H1167978924"><span class="h1">ANATOMIC CONSIDERATIONS</span><span class="headingEndMark"> — </span>Knowledge of the normal and variant anatomy of the vena cava is important for successful placement of vena cava filters and prevention of complications. </p><p>The major veins of the upper and lower extremity drain into the central veins. In the upper extremity, the subclavian veins arch cephalad behind the medial clavicle and then slope caudally to join the internal jugular veins and form the brachiocephalic (innominate) veins  (<a class="graphic graphic_figure graphicRef74801" href="/z/d/graphic/74801.html" rel="external">figure 2</a>). The thyroid veins contribute to the left brachiocephalic vein, and, together with the right brachiocephalic vein and azygos vein, these join to form the superior vena cava (SVC), which drains into the right atrium. </p><p>In the lower extremity, the common femoral veins become the external iliac veins after passing below the inguinal ligament  (<a class="graphic graphic_figure graphicRef75219" href="/z/d/graphic/75219.html" rel="external">figure 3</a>). They are joined by the internal iliac veins to form the common iliac veins. The common iliac veins merge at the level of the umbilicus to form the inferior vena cava (IVC) at the L5 level. It continues superiorly to the right of the aorta and receives multiple lumbar tributaries. At the L1 to L2 level, the right and left renal veins join the IVC, and this junction divides the IVC into the infrarenal and suprarenal portions. Because the IVC is usually located to the right of the spine, the left common iliac vein is longer with a less vertical path to the IVC. </p><p>The tributaries to the IVC (caudal to cranial) include the median sacral vein, the paired lumbar veins, the right gonadal vein (the left usually drains into the left renal vein), the left and right renal veins, the right suprarenal vein (the left usually drains into the left renal vein), the hepatic veins (right, left, middle), and the inferior phrenic veins  (<a class="graphic graphic_figure graphicRef95450" href="/z/d/graphic/95450.html" rel="external">figure 4</a>).</p><p class="headingAnchor" id="H3575757479"><span class="h2">Venous abnormalities</span><span class="headingEndMark"> — </span>Venous abnormalities that may be encountered include narrowing of an access vein or the vena cava, which may impede the ability to successfully traverse it with the device. Narrowing can be due to intrinsic stricture or thrombus or to extrinsic compression and may require balloon dilation or even stent placement to facilitate successful deployment of the filter. The anatomy may dictate the most appropriate approach (ie, internal jugular, femoral). The possibility of congenital anomalies also needs to be entertained as they can impact the placement of vena cava filters. In one study, variants caused alteration in the placement or selection of IVC filters in 18 percent of patients [<a href="#rid38">38</a>]. Whether preprocedure imaging is necessary for all patients prior to vena cava filter placement to identify venous abnormalities is controversial. However, if computed tomography (CT) or magnetic resonance (MR) imaging of the abdomen/pelvis is available, the study should be evaluated for possible abnormalities or anomalies. (See <a class="local">'Venous imaging'</a> below.)</p><p>Congenital anomalies of the IVC and its tributaries have been identified more frequently in asymptomatic patients due to the increased use of cross-sectional imaging. It is important to be able to recognize the more common variations in order to interpret the possible aberrant course of the guidewire during vena cava filter placement, particularly if preprocedure imaging has not been performed. Anomalies occur in 5 to 15 percent of individuals [<a href="#rid26">26</a>]. Duplicated and left-sided vena cava, as well as a circumaortic left renal vein, are among the more common anomalies  (<a class="graphic graphic_figure graphicRef95452 graphicRef95451" href="/z/d/graphic/95452.html" rel="external">figure 5A-B</a>) [<a href="#rid39">39,40</a>]. Anomalies of the renal veins may lead to drainage at a more superior or inferior location. Multiple anomalies involving the SVC and thoracic vessels have been reported, often in association with complex cardiac or great vessel defects, and these anomalies can create confusion and difficulty with SVC filter placement but are rare.</p><p class="headingAnchor" id="H5674522"><span class="h1">PREPARATION AND PLANNING</span><span class="headingEndMark"> — </span>Patients should undergo a general assessment prior to placement of a vena cava filter. Prior to placement of an inferior vena cava (IVC) filter, coagulation parameters including the prothrombin time (PT), partial thromboplastin time (PTT), and international normalized ratio (INR) should be obtained. For older patients, those with hypertension or diabetes, and any others at increased risk for contrast-induced renal insufficiency, we obtain renal function tests such as blood urea nitrogen and creatinine. </p><p>Antibiotic prophylaxis is not routinely recommended for IVC filter placement  (<a class="graphic graphic_table graphicRef63103" href="/z/d/graphic/63103.html" rel="external">table 1</a>). If the patient has been treated for infection, then antibiotics should be continued.</p><p class="headingAnchor" id="H5675152"><span class="h2">Venous imaging</span><span class="headingEndMark"> — </span>A venocavogram is usually a requirement prior to positioning and deploying the IVC filter, but whether other preprocedure imaging is needed is controversial. </p><p>At a minimum, sonography of the access site should be performed to ensure that it is free of thrombus. Some vascular interventionalists perform duplex ultrasound of the femoral veins, iliac veins, and IVC prior to all filter placements, but this may not be feasible in all patients depending on body habitus. Cross-sectional imaging is not necessary in most patients, but if the patient has had a recent computed tomography (CT) or magnetic resonance (MR) study of the abdomen, the interventionalist should take the opportunity to review it or any other available abdominal and pelvic imaging to detect any abnormalities that might interfere with or alter the placement strategy [<a href="#rid41">41</a>]. The presence of a duplicated IVC, the diameter of the IVC, and the position and anomalies of the renal veins can be seen on CT or MR imaging. Although the CT and/or MR imaging may be very helpful for evaluating normal and variant anatomy, unless imaging was very recent, these may not demonstrate thrombus within the IVC.</p><p>The venocavogram is evaluated for several important aspects: duplication or other anomalies of the IVC, diameter of the vena cava, positioning of the renal veins, or the presence of clot within the IVC. (See <a class="local">'Filter placement'</a> below.) </p><p class="headingAnchor" id="H420424433"><span class="h2">Bedside placement</span><span class="headingEndMark"> — </span>IVC filters are most typically placed with fluoroscopy to guide the final position of the filter, which requires intravenous contrast and transport of the patient to the interventional suite, which may be more difficult in critically ill patients. </p><p>Placement of IVC filters can be performed using bedside fluoroscopy. This requires having an intensive care unit (ICU) bed that can accommodate an angiographic C-arm. Alternatively, bedside placement can be performed using transabdominal or intravascular ultrasound (IVUS). Ultrasound-guided IVC placement has been performed with technical success and without significant increases in complication rates [<a href="#rid42">42-49</a>]. In a review that included 398 patients who underwent attempted bedside IVC filter placement, overall technical success was 99.2 percent [<a href="#rid42">42</a>]. The filter was malpositioned in three cases. The overall procedure-related complication rate was 3 percent. Transabdominal ultrasound can be very difficult or impossible to do accurately in patients who are obese or who have significant abdominal wounds. In these cases, IVUS can be used by experienced operators to identify the position of the renal veins and the size of the IVC and to guide placement of the filter [<a href="#rid42">42,45,46,48</a>]. Additional training is needed to master ultrasound-guided techniques [<a href="#rid44">44,47</a>]. </p><p class="headingAnchor" id="H420424696"><span class="h2">Venous access site</span><span class="headingEndMark"> — </span>All vena cava filters can be placed using an internal jugular or femoral approach  (<a class="graphic graphic_table graphicRef51423" href="/z/d/graphic/51423.html" rel="external">table 2</a>). Some can be placed via an upper extremity peripheral vein approach (usually the brachial or basilic vein). Placement from the upper arm may require a longer sheath for positioning of the filter. The selection of a central venous access site to place a vena cava filter for a given patient takes into account similar considerations as with placement of any central venous device such as prior access history, site of known venous stenosis or thrombosis, bleeding risk, body mass index, possibly the presence of any venous anomalies (if known), and, to some degree, the patient's preference or condition. As examples, if the patient has a condition that requires ongoing bedrest, then a femoral approach may be reasonable. If the patient has a need for head elevation (intracranial pressure), then a jugular approach may be more appropriate. (See  <a class="medical medical_review" href="/z/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Access site'</a> and  <a class="medical medical_review" href="/z/d/html/8194.html" rel="external">"Central venous access in adults: General principles", section on 'Device and site selection'</a>.)</p><p>A right-sided approach, regardless of access vessel, is generally preferred over the left side given the more direct route to the IVC. As with any central venous access procedure, ultrasound-guided access is recommended. (See  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access"</a>.)</p><p>Some authors, but not all, have suggested that an internal jugular vein approach may be preferred to decrease the risk for subsequent femoral vein thrombosis that could be related to femoral vein injury at the time of placement, particularly in patients receiving prophylactic filters. (See <a class="local">'Acute and recurrent deep vein thrombosis'</a> below.)</p><p>During the procedure, the femoral vein approach is somewhat more comfortable for the patient and is also somewhat easier for the operator, since the catheters and guidewires can be placed onto the draped angiographic table, making sterility a little easier to maintain. The right femoral vein has a very direct course to the IVC. There are no obstacles to placing guidewires, catheters, or the filter. The operator does need to be aware when using a right common femoral approach that a duplicated IVC can be missed, if not specifically sought. The easiest way to exclude a left-sided IVC is to determine that there is a left common iliac vein, which would not be present with a left-sided IVC. Placement of a filter from the left femoral vein has a tendency to cause some tilting of the filter as the sheath and filter tend to be directed at the right lateral wall of the IVC. Commonly, an ultrasound of the lower extremities has been previously performed to evaluate the patient for the presence of deep vein thrombosis (DVT). Presence of thrombus in the common femoral vein would change the access approach. The iliac veins may or may not be seen well on an ultrasound examination, so if a femoral vein approach is being chosen, some practitioners will perform an iliofemoral contrast injection from the femoral vein to demonstrate that there is no clot in the iliac vein. This is particularly important if a left common femoral vein approach is being used since there is an increased incidence of DVT involving the left iliofemoral system.</p><p>For a jugular approach, a separate sterile table is needed upon which to place instruments and from which to pass guidewires and sheaths. Also, many patients are uncomfortable having their face covered, but following the procedure, the patient can get out of bed, which tends to make their postprocedure recovery much more comfortable. The internal jugular approach has certain pitfalls that an operator must be aware of when placing a filter. There is the risk of pneumothorax, which should be minimized by using ultrasound guidance while obtaining access into the internal jugular vein. Occasionally, difficulty passing a sheath beneath the clavicle will occur. Also, access into the inferior vena cava is achieved by passing guidewires and sheaths through the right atrium and liver while avoiding the hepatic veins. Traversing the right atrium can cause arrhythmias, which usually resolve with changing the position of the catheter, but a few individuals may be very sensitive to catheter manipulation. </p><p>Lastly, it is important to realize that inadvertent cannulation of the right gonadal vein can occur when access is from above (jugular, peripheral upper extremity vein access). The right gonadal vein usually enters the IVC just inferior to the right renal vein and has a course that is parallel and just lateral to the IVC. (See <a class="local">'Filter placement'</a> below.)</p><p class="headingAnchor" id="H3961688"><span class="h1">FILTER PLACEMENT</span><span class="headingEndMark"> — </span>The chosen access site should be prepared using standard techniques. As with any central venous access procedure, we recommend sterile technique, including full barrier precautions, and sterile drapes to cover the entire patient. Ultrasound imaging during needle placement reduces time to venous cannulation and reduces the risk of complications during central venous access. (See  <a class="medical medical_review" href="/z/d/html/6315.html" rel="external">"Basic principles of ultrasound-guided venous access"</a>.)</p><p>Once venous access has been established, a guidewire is used to access the vena cava over which a catheter, or sheath and catheter, can be placed to perform a venocavogram. In patients with severe allergic reactions to contrast or with renal insufficiency, the inferior venocavogram and any selective renal injections can be performed with CO<sub>2</sub>. When using a jugular approach, the catheter should ideally be placed into the left common iliac vein for the injection of contrast to exclude a duplicated inferior vena cava (IVC). If the approach is from a femoral vein, contrast should be injected into the ipsilateral common iliac vein (not vena cava) to clearly delineate the origin of the contralateral common iliac vein. The venocavogram should first be inspected for evidence of thrombus. If occlusion is demonstrated on a femoral approach, then a jugular approach may be required to demonstrate the upper extent of the occlusion. If a clot is demonstrated, a change in the position of the filter may be needed, such as suprarenal positioning. If there is a chronic occlusion of the cava, then filter placement may not be needed. </p><p>When interpreting the venocavogram, the operator should be alert for any subtle findings suggesting common venous anomalies  (<a class="graphic graphic_figure graphicRef95452 graphicRef95451" href="/z/d/graphic/95452.html" rel="external">figure 5A-B</a>). Although there may be inflow of nonopacified blood from the renal veins, a circumaortic renal vein can be missed because the inflow from the lower branch is subtle. Many operators routinely selectively catheterize the renal vein to identify anomalies that would require a change in the position of the filter. The most common of these anomalies is a duplication of the left renal vein, usually with a circumaortic lower branch. However, accidental cannulation of retroperitoneal veins during venography for IVC filter placement is an infrequent occurrence and does not usually result in negative clinical outcomes [<a href="#rid50">50</a>]. Inadvertent cannulation of the right gonadal vein with access from above can appear similar to that of the IVC. Such inadvertent positioning would be readily determined by a test injection of contrast. The guidewire can also slip into the right gonadal vein during exchange of the catheter used for the inferior venocavogram. If this happens, the IVC filter sheath could easily be placed into the right gonadal vein, and if the operator is not aware of the slight change in the trajectory of the wire, deployment of the filter in the right gonadal vein will result. The filter will be constrained and will not expand, and if the filter cannot be retrieved safely, another IVC filter will need to be deployed.</p><p>Because the IVC is frequently oval (rather than round), the diameter of the IVC should be measured in both the anteroposterior and lateral projections and documented to ensure it does not exceed the upper limit for the planned filter. Many operators use a marker catheter to obtain an accurate measurement. If the diameter of the cava is too large on the anteroposterior (AP) projection, but the diameter obtained from the lateral projection is within the manufacturer's instructions for use (IFU), then the filter can be carefully placed. The IVC filter will first usually catch from the front to back of the cava (the narrowed end will tend to round out the cava, allowing the legs to attach right to left). Similarly, if the diameter in the lateral projection is too large, but the diameter obtained from the AP projection is within the IFU, then the IVC filter will catch from right to left of the cava, again tending to round it out, allowing the legs to attach from front to back.</p><p>The instructions for use for the individual device should be followed to position and deploy the device. Although not usually an issue during IVC placement, when fluoroscopy is being used, it is important to avoid advancing any guidewires beyond the filter once it has been deployed; there is a risk, particularly with J-type wires, for the guidewire to be entangled in the filter. More important is the problem of guidewire entrapment with subsequent placement of central vein catheters where the guidewire may be advanced into the IVC and become entangled in the filter [<a href="#rid51">51</a>]. (See <a class="local">'Guidewire entrapment with central line placement'</a> below.)</p><p>Following filter placement, the sheath is removed and pressure applied to the access site until hemostasis is achieved. A small piece of gauze held in place with self-adhesive film dressing is sufficient.</p><p class="headingAnchor" id="H5674830"><span class="h2">Filter positioning</span><span class="headingEndMark"> — </span>The filter should be placed in a location that will reduce the risk of venous thromboembolism through all the likely venous pathways. With standard anatomy, the filter should be positioned with the tip of the filter just at the inflow of the renal veins, which minimizes the accumulation of thrombus above the filter in the event of filter thrombosis. If the filter thrombosis is substantially below the renal vein inflow, then the dead space between the thrombosed filter and the renal veins would allow a clot to form, potentially leading to pulmonary embolism. IVC filters placed across the renal veins may have no significant effect on renal function, but they may not be stable in a pararenal location due to the inability of fixation mechanisms to fully engage the IVC wall [<a href="#rid52">52</a>]. </p><p>If a circumaortic left renal vein is present, then if possible, the filter should be placed inferior to the lower limb of the renal vein. The rationale is that the circumaortic vein can serve as a conduit for thrombus to pass from the lower extremities through the left renal system and into the lungs. This is particularly a concern if a filter above a circumaortic left renal vein thromboses. In some cases, the lower of the renal vein limb is close to the confluence of the iliac veins, and there is not enough room to put the filter below the lower limb and above the confluence. In this case, a decision needs to be made whether to place the filter spanning the lower limb but with the legs of the filter in the IVC above the confluence of the iliac veins (the more common approach) or to place IVC filters in the iliac veins bilaterally. Placement covering the renal veins potentially places veins at risk for damage/thrombosis, but there is no evidence of complications from this approach [<a href="#rid52">52</a>].</p><p>In the setting of duplication of the IVC, a filter should be placed in each of the left and right IVC segments. </p><p class="headingAnchor" id="H2176225027"><span class="h2">Suprarenal or SVC placement</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suprarenal filter placement</strong> – Suprarenal filter placement appears to be safe (although considered off-label use in the United States), when necessary [<a href="#rid53">53</a>]. Indications for placement of a suprarenal filter include renal vein thrombosis, gonadal vein thrombosis, IVC thrombus extending above the renal veins, and thrombus in the infrarenal IVC that does not provide sufficient room for the filter to be placed above the thrombus and below the renal veins. For those who are pregnant, the vena cava filter is usually positioned in a suprarenal position [<a href="#rid54">54</a>]. Suprarenal placement may increase stresses experienced by the filter, potentially increasing the risk for complications. (See <a class="local">'Complications'</a> below and  <a class="medical medical_review" href="/z/d/html/1350.html" rel="external">"Venous thromboembolism in pregnancy and postpartum: Treatment", section on 'Patients at high bleeding risk or contraindications to anticoagulation: IVC filter'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Superior vena cava placement</strong> – The placement of filters in the superior vena cava (SVC) for patients with upper extremity deep vein thrombosis and contraindications to anticoagulation has been well described, but there is much less experience with this indication and technique [<a href="#rid55">55-57</a>]. It is important to note that vena cava filters are <strong>not</strong> a routine part of the management of upper extremity deep venous thrombosis, which is discussed in detail elsewhere. One review of 154 patients undergoing SVC filter placement noted that over a mean follow-up of 628 days, 74 percent of patients died as a result of their chronic illness or from cancer complications [<a href="#rid58">58</a>]. Three cases of perforation leading to pericardial tamponade occurred. (See  <a class="medical medical_review" href="/z/d/html/8211.html" rel="external">"Primary (spontaneous) upper extremity deep vein thrombosis"</a> and  <a class="medical medical_review" href="/z/d/html/8195.html" rel="external">"Catheter-related upper extremity venous thrombosis in adults"</a>.)</p><p></p><p class="headingAnchor" id="H501418"><span class="h2">Documentation</span><span class="headingEndMark"> — </span>All patients who have undergone placement of a vena cava filter should have proper documentation and have an alert placed on their chart [<a href="#rid51">51</a>]. The patient should also be made aware of potential issues related to its placement. Ideally, they should have identification to alert medical personnel of its presence to prevent future inadvertent venous cannulation that may dislodge the filter or lead to guidewire entrapment. If the filter is planned to be a temporary filter, then it is critical to make sure there is a tracking mechanism to ensure the patient comes back for removal. The patient and family and caregivers should be educated that the filter should be removed when possible. (See <a class="local">'Guidewire entrapment with central line placement'</a> below.)</p><p class="headingAnchor" id="H5673588"><span class="h1">FILTER RETRIEVAL</span><span class="headingEndMark"> — </span>Manufacturer recommendations for timing of filter retrieval vary; retrieval success decreases as duration of placement increases; however, filter retrieval following a prolonged duration of time has been reported [<a href="#rid59">59-62</a>]. The success of late filter retrieval is dependent upon the degree of strut epithelialization that has occurred [<a href="#rid62">62</a>] but is less successful and generally should only be attempted by experienced operators. Retrieval of "permanent" filters has also been described [<a href="#rid32">32,63</a>]. </p><p>In a systematic review, the overall retrieval rate among 6834 patients was 34 percent [<a href="#rid64">64</a>]. In spite of a high rate of technical success when filter retrieval is attempted, a high percentage of patients are not scheduled for filter retrieval for a variety of reasons [<a href="#rid64">64-67</a>]. In case series, up to 30 percent of patients are lost to follow-up; this is particularly true in trauma centers [<a href="#rid65">65,68,69</a>]. In one review at a large trauma center, an attempt to remove a previously placed retrievable filter was made in only 10.3 percent of the patients [<a href="#rid66">66</a>]. Among these attempts, 18.3 percent were unsuccessful. Many of the filters were placed because of a contraindication to anticoagulation; however, 24.9 percent of patients who received a retrievable inferior vena cava (IVC) filter were discharged on anticoagulant therapy, most with the filter still in place. In a review of retrievable filters among patients with and without active cancer, although cancer was not associated with filter-related complications, it was associated with a significantly lower rate of filter retrieval compared with those without cancer (28 versus 42 percent) [<a href="#rid70">70</a>]. Additional risk factors identified in a study of 605 filters, for which the retrieval rate was only 25 percent, were predominantly related to limited life expectancy (eg, age &gt;80 years) or unresolved underlying conditions (eg, bleeding, pulmonary embolism, deep vein thrombosis) [<a href="#rid71">71</a>].</p><p>As a result of such reports, the US Food and Drug Administration has expressed concern over the relatively low frequency with which retrievable filters are removed and has recommended that "implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider removing the filter as soon as protection is no longer needed" [<a href="#rid24">24,32</a>].</p><p>Several studies have found an increased effectiveness of physician education and systematic patient follow-up to assure removal of retrievable filters at the appropriate interval after placement [<a href="#rid69">69,72-78</a>]. With such a program in place, up to 75 percent of retrievable filters are successfully removed. But even when posthospital care can be tracked and there is an opportunity for removal, most patients do not have their filters removed primarily because of continued care in an extended care facility or an ongoing indication for the filter. However, one review demonstrated that the rate of filter retrieval was increased 14-fold after the development of a retrieval program in a level 1 trauma center [<a href="#rid79">79</a>]. The retrievable filters are all approved for permanent placement indications and have largely replaced the older filters that had permanent indications. However, the long-term safety of the retrievable filters compared with permanent filters is largely unknown. (See  <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">"Treatment, prognosis, and follow-up of acute pulmonary embolism in adults", section on 'Inferior vena cava filters'</a> and <a class="local">'Types of filters'</a> above.)</p><p class="headingAnchor" id="H5674921"><span class="h2">Embedded filters</span><span class="headingEndMark"> — </span>Although filter retrieval is achieved in 80 to 90 percent of attempts [<a href="#rid60">60,80-85</a>], removal of the filter can be technically challenging and potentially unsuccessful [<a href="#rid86">86-88</a>]. Reasons for failed attempts include excessive tissue ingrowth, thrombus within the filter, and filter tilt. A period of anticoagulation may hasten resolution of the thrombus, allowing for subsequent filter removal [<a href="#rid89">89</a>]. There have been a number of techniques described in the literature to remove these filters other than with the prepackaged retrieval devices [<a href="#rid90">90-99</a>]. Such techniques include the use of rigid forceps, modified loop snare, or double loop techniques, use of balloon displacement, or use of Excimer laser sheath, among others [<a href="#rid90">90-99</a>]. Each of these advanced techniques carries the potential risk of hemorrhage, distortion, or breakage of the filter and other complications. These techniques should be performed only by experienced interventionalists, and if the filter is difficult to remove using standard techniques, it may be more prudent to leave the filter in place, depending on the need for removal, rather than using aggressive techniques that might damage the filter or injure the IVC. </p><p class="headingAnchor" id="H5674600"><span class="h1">POSTPROCEDURE CARE</span><span class="headingEndMark"> — </span>Following vena cava filter placement, the patient is usually kept on bed rest; the length of time depends on the approach. For patients with jugular filter placement, the head of the bed should be elevated to 45 degrees or more for approximately two hours. If the patient has had the filter placed from a femoral approach, most patients will remain at bed rest for four hours with the access leg straight. If the patient is on anticoagulation at the time of the procedure, the time of bed rest may need to be increased.</p><p>Whether to anticoagulate the patient following vena cava filter placement if the contraindication to anticoagulation has resolved is controversial. Some patient populations are at increased risk for thrombosis (eg, patients with malignancy) such that initiating anticoagulation, if feasible, may reduce the rate of filter-related complications [<a href="#rid100">100</a>]. This decision should be based upon the clinical circumstances that indicated the need for filter placement. (See  <a class="medical medical_review" href="/z/d/html/1362.html" rel="external">"Overview of the treatment of proximal and distal lower extremity deep vein thrombosis (DVT)", section on 'Inferior vena cava filter'</a>.)</p><p class="headingAnchor" id="H22564436"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications of inferior vena cava (IVC) filters include those associated with filter placement, such as bleeding or infection at the puncture site; allergic reactions to contrast or other medications used during placement; malposition of the filter; entrapment of the guidewire within the filter; postprocedure complications related to the access site, such as acute venous thrombosis, hematoma, or arteriovenous fistula; and longer-term complications, such as filter erosion/migration or embolization, and chronic thrombosis/recurrent thromboembolism [<a href="#rid60">60,66,101-103</a>]. </p><p>There are insufficient data to compare the safety and efficacy of specific types of IVC filters. The Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) trial, a trial initiated in 2014 and jointly sponsored by the Society of Interventional Radiology and the Society for Vascular Surgery, was designed to evaluate the safety and efficacy of six different commercially available IVC filters (permanent and retrievable) over the long term [<a href="#rid104">104</a>]. </p><p>Complication rates may be higher with retrievable compared with nonretrievable filters. In a review of data from the US Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE), self-reported complication rates with retrievable filters were significantly higher compared with the self-reported complication rates for permanent filters [<a href="#rid105">105</a>]. </p><p class="headingAnchor" id="H22564608"><span class="h2">Acute and recurrent deep vein thrombosis</span><span class="headingEndMark"> — </span>Although filter placement may protect the pulmonary vascular bed, it does nothing to lessen the thrombotic predisposition or the incidence of lower extremity venous thrombosis. Acute insertion site thrombosis has been reported in up to 40 percent of patients undergoing filter placement; however, this appears to be more common in older literature when using both a femoral approach and a large introducer [<a href="#rid106">106-110</a>]. Among patients for whom IVC filters have been placed for a contraindication to anticoagulation, the rate of deep vein thrombosis is overall low (2 to 4 percent) [<a href="#rid111">111-114</a>]. </p><p>A retrospective review identified 35 patients who had a duplex ultrasound study following IVC filter placement [<a href="#rid110">110</a>]. The indications for filter placement were deep vein thrombosis (DVT) in 16 patients, pulmonary embolus in 13 patients, DVT and pulmonary embolus in 3 patients, and prophylactic filter in 3 patients at high risk for thromboembolization. At a mean follow-up of 12±2 days (median 6 days), the incidence of proximal DVT in venous segments without evidence of thrombosis before filter insertion was 40 percent, of which 71 percent occurred in the common femoral vein. Three were located in the femoral vein, and one was in the external iliac vein. Smaller-diameter filters were not associated with a lower incidence of femoral thrombosis compared with larger-diameter filters. The incidence of thrombosis was higher in patients with preinsertion pulmonary emboli compared with those patients with DVT (50 versus 38 percent) and prophylactic insertion (50 versus 0 percent). However, these subgroups were too small to attain statistical significance. </p><p>In a retrospective review (data obtained from querying a California Patient Discharge database), among 80,697 noncancer patients with no contraindication to anticoagulation, patients with and without a vena cava filter were compared [<a href="#rid114">114</a>]. The incidence of DVT within one year was 5.4 percent among filter patients and 3.7 percent among no-filter patients. However, in a group of patients who had active bleeding and presumably a contraindication to anticoagulation, patients with a filter had a 32 percent reduction in the adjusted risk of death at 30 days compared with no filter (9.5 versus 11.5 percent). Filter use remained associated with a similar significant reduction in the risk of death at 90 days after admission. These findings are consistent with recommendations that IVC filters are more appropriately reserved for those patients with DVT/pulmonary embolism who have a contraindication to anticoagulation.</p><p>The incidence of venous thrombosis may increase with time. One trial randomly assigned 400 patients to receive a permanent IVC filter (VenaTech, Greenfield, Bird's Nest, or Cardial IVC) plus anticoagulation or anticoagulation alone [<a href="#rid108">108,109</a>]. Recurrent DVT was more common in the group that received an IVC filter. The incidence of DVT at two years was 21 percent in the IVC filter group compared with 12 percent in the no-filter group. At eight years, the incidence was increased at 36 versus 28 percent, respectively. However, patients with filters were less likely to experience a symptomatic pulmonary embolism (6 versus 15 percent). The overall mortality and incidence of post-thrombotic syndrome were similar in both groups. </p><p>A later study evaluated the risk of insertion-site thrombosis of the femoral vein after predominantly prophylactic filter placement using contemporary devices [<a href="#rid106">106</a>]. None of the 56 patients studied had thrombus formation at the insertion site. Filters were placed for prophylaxis in 73 percent of the patients, and the remaining filters were placed for therapeutic indications.</p><p class="headingAnchor" id="H5673628"><span class="h2">IVC thrombosis</span><span class="headingEndMark"> — </span>IVC obstruction has been reported in 3 to 30 percent of patients following IVC filter placement (permanent or retrievable) related to new local thrombus formation, thrombogenicity of the device, trapped embolus, or extension of a more distal DVT cephalad [<a href="#rid112">112,115-118</a>]. Although caval obstruction can be asymptomatic, it may result in lower extremity edema, increase the risk of other sequelae of venous insufficiency (eg, stasis ulcers), and result in the development of collateral vessels that may serve as a route for recurrent embolization [<a href="#rid8">8,119,120</a>]. Endovenous techniques have been successfully used to recanalize IVC occlusions and reduce symptoms, but rethrombosis is common [<a href="#rid120">120</a>]. (See  <a class="medical medical_review" href="/z/d/html/15222.html" rel="external">"Endovenous intervention for iliocaval venous obstruction"</a>.) </p><p class="headingAnchor" id="H22564719"><span class="h2">Recurrent pulmonary embolism</span><span class="headingEndMark"> — </span>Small thrombi are capable of passing through patent filters or through collaterals around obstructed filters; furthermore, direct thrombus extension can occur through the filter itself leading to recurrent pulmonary embolism. However, data suggest that recurrent pulmonary embolism is unusual following filter insertion (2 to 4 percent in most series) [<a href="#rid8">8,9,64,108,109,121-123</a>]. Pharmacomechanical thrombolysis is an adjunct that has been used to treat patients with severe symptoms [<a href="#rid124">124</a>]. (See  <a class="medical medical_review" href="/z/d/html/15222.html" rel="external">"Endovenous intervention for iliocaval venous obstruction"</a>.)</p><p>The thrombotic complications related to prophylactic IVC filter placement in at-risk populations such as trauma, neurosurgery, oncology, intensive care, and bariatric patients are poorly defined. Data come from diverse studies; in some, pulmonary embolism is specifically sought, and in others only clinically documented pulmonary emboli are reported. </p><p>One systematic review of retrievable IVC filters estimated an incidence of pulmonary embolism following filter placement of 1.3 percent [<a href="#rid64">64</a>]. A later randomized trial compared retrievable IVC filters plus anticoagulation with anticoagulation alone in patients with pulmonary embolism and a high risk of recurrence [<a href="#rid125">125</a>]. The rate of symptomatic recurrent pulmonary embolism was 3 percent in the filter group, which was not significantly different from the control group at 1.5 percent. Filters were retrieved overall in 85 percent of patients and in 93 percent in whom it was planned and attempted. This study demonstrates that if a patient can be anticoagulated, filter placement will not add any additional protection. In addition, it would suggest that once the patient can be anticoagulated, the filter should be removed since it is not adding any benefit. </p><p>A large number of reports on individual filters have been published; however, clearly defined endpoints and objective criteria for reporting recurrence and mortality rates are lacking [<a href="#rid126">126,127</a>].</p><p class="headingAnchor" id="H6042814"><span class="h2">Guidewire entrapment with central line placement</span><span class="headingEndMark"> — </span>Guidewire entrapment, particularly with J-tipped wires, is a known complication of central line placement [<a href="#rid128">128-132</a>]. The guidewire can become entangled in the apex of the IVC filter. The placement of central venous devices in the intensive care setting has increased the number of incidents in which the guidewire becomes entrapped in a vena cava filter [<a href="#rid130">130</a>]. Since the majority of central lines are placed from the upper extremity or internal jugular veins, the incidence of guidewire entrapment is higher from an upper compared with lower extremity approach, and displacement of the filter into undesirable structures is more likely. However, entrapment of guidewires from the femoral approach can occur.</p><p>An in vitro study compared the risk of engaging and entrapping guidewires in eight IVC filters available in the United States, including two types of Greenfield filters, Simon Nitinol, Bird's Nest, VenaTech LGM, VenaTech LP, TrapEase, and Günther Tulip, using four different wires (15 mm, 3 mm, and 1.5 mm J-tipped, and straight) [<a href="#rid132">132</a>]. Engagement was defined as a filter/wire interaction causing the filter or wire to become deformed. The wires were passed through each filter 100 times, 50 from a jugular approach and 50 from a femoral approach. Although the straight wire did not engage any of the filters, each of the J-tipped wires engaged in all the filters tested. The VenaTech LP and Günther Tulip filters did not entrap any of the wires. The force required to disengage entrapped wires resulted in structural damage to the wire and/or filter. </p><p>If the operator placing a central line finds there is resistance in trying to remove the wire, the operator should immediately stop trying to remove the wire. If the wire is pulled, the IVC filter can become dislodged, distorted, or moved into a very undesirable position (right heart, superior vena cava, innominate, jugular veins). An abdominal plain film (KUB) should be obtained to assess the position of the wire. If it appears to be in contact with a filter, then a vascular interventionalist should be consulted for help in removing the wire. With careful maneuvering using fluoroscopy, the wires can usually be extracted. </p><p class="headingAnchor" id="H1412731692"><span class="h2">Filter migration, erosion, fracture</span><span class="headingEndMark"> — </span>Other late complications of IVC filter placement are uncommon. Most of these complications are reported in individual case studies, and there are otherwise few data to determine the factors that are responsible. These include filter migration [<a href="#rid133">133-137</a>], which can also occur acutely during filter placement; filter erosion and perforation through the IVC wall and into adjacent structures [<a href="#rid103">103,138-153</a>]; and filter fracture and fragment embolization [<a href="#rid154">154-161</a>]. Migration of the filter or fragments into the right atrium, pulmonary artery, right gonadal vein, lumbar veins, and even into the aorta have been reported [<a href="#rid162">162</a>]. Percutaneous image-guided removal of migrated or fractured filters and associated filter fragments can usually be accomplished if they are intravascular, but the success rate varies depending upon anatomic location [<a href="#rid138">138,163</a>]. </p><p class="headingAnchor" id="H22564487"><span class="h1">MORTALITY</span><span class="headingEndMark"> — </span>Mortality from filter placement appears to be quite low, regardless of which filter is used. As examples, three deaths (0.12 percent) were reported in a review of 2557 patients undergoing filter insertion [<a href="#rid112">112</a>], and a second series of 1765 insertions had a major complication rate of 0.3 percent [<a href="#rid164">164</a>]. However, patients who receive permanent IVC filters have high mortality with follow-up (50 percent at a mean follow-up of 36 months in one study [<a href="#rid165">165</a>]).</p><p class="headingAnchor" id="H2857683647"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113663.html" rel="external">"Society guideline links: Superficial vein thrombosis, deep vein thrombosis, and pulmonary embolism"</a>.)</p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Inferior vena cava (IVC) filters may be used for the treatment of venous thromboembolic disease when a patient is not a candidate for anticoagulant therapy or has failed anticoagulant therapy or in those with a limited ability to tolerate subsequent pulmonary emboli (eg, patients with acute hemodynamically massive pulmonary embolism or chronic thromboembolic pulmonary hypertension). (See  <a class="medical medical_review" href="/z/d/html/8265.html" rel="external">"Treatment, prognosis, and follow-up of acute pulmonary embolism in adults", section on 'Inferior vena cava filter'</a> and <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prophylactic IVC filter placement may be an option for carefully selected patients at high risk for venous thromboembolism in whom pharmacologic or mechanical prophylaxis is contraindicated or has proven ineffective. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two general types of vena cava filters are available: permanent and retrievable. When retrievable IVC filters are used, it is important to create a plan for removing the filter as soon as protection is no longer needed (ie, once the patient can be anticoagulated). In spite of a high rate of technical success when removal of a retrievable filter is attempted, a high percentage of patients are not scheduled for filter retrieval for a variety of reasons. Even when there is an opportunity, most patients do not have their filters removed primarily because of continued care in an extended care facility or an ongoing indication for the filter. (See <a class="local">'Types of filters'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There are insufficient data to compare the safety and efficacy of specific types of IVC filters. Until there is more clinical experience with temporary or retrievable filters, clinicians should consider the decision to place a filter irrevocable and, given the absence of long-term follow-up studies, one that requires careful consideration. (See <a class="local">'Mortality'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Complications of IVC filters can include deep vein thrombosis at the insertion site; IVC thrombosis; recurrent pulmonary embolism; and filter erosion, fracture, or migration. Migration can be due to guidewire entrapment and inadvertent dislodgement during central line placement. If an operator experiences resistance when trying to remove a guidewire in a patient with an IVC filter, abdominal imaging should be obtained to assess the position of the wire relative to the filter. Using fluoroscopy, the wire can usually be separated from the filter and extracted. (See <a class="local">'Complications'</a> above.) </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Meisner RJ, Labropoulos N, Gasparis AP, et al. Review of indications and practices of vena caval filters at a large university hospital. Vasc Endovascular Surg 2012; 46:21.</a></li><li><a class="nounderline abstract_t">Baadh AS, Zikria JF, Rivoli S, et al. Indications for inferior vena cava filter placement: do physicians comply with guidelines? J Vasc Interv Radiol 2012; 23:989.</a></li><li><a class="nounderline abstract_t">White RH, Geraghty EM, Brunson A, et al. High variation between hospitals in vena cava filter use for venous thromboembolism. JAMA Intern Med 2013; 173:506.</a></li><li><a class="nounderline abstract_t">Meltzer AJ, Graham A, Kim JH, et al. Clinical, demographic, and medicolegal factors associated with geographic variation in inferior vena cava filter utilization: an interstate analysis. Surgery 2013; 153:683.</a></li><li><a class="nounderline abstract_t">Knudson MM. Hospital-specific risk factors for filter fever. JAMA Surg 2013; 148:687.</a></li><li><a class="nounderline abstract_t">Hemmila MR, Osborne NH, Henke PK, et al. Prophylactic Inferior Vena Cava Filter Placement Does Not Result in a Survival Benefit for Trauma Patients. Ann Surg 2015; 262:577.</a></li><li><a class="nounderline abstract_t">Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160:e545.</a></li><li><a class="nounderline abstract_t">Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149:315.</a></li><li><a class="nounderline abstract_t">Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.</a></li><li><a class="nounderline abstract_t">Kaufman JA, Barnes GD, Chaer RA, et al. Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol 2020; 31:1529.</a></li><li><a class="nounderline abstract_t">Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e227S.</a></li><li><a class="nounderline abstract_t">Turner TE, Saeed MJ, Novak E, Brown DL. Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality. JAMA Netw Open 2018; 1:e180452.</a></li><li><a class="nounderline abstract_t">Secemsky EA, Carroll BJ, Yeh RW. Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device? JAMA Netw Open 2018; 1:e180453.</a></li><li><a class="nounderline abstract_t">Stein PD, Matta F. Vena cava filters in unstable elderly patients with acute pulmonary embolism. Am J Med 2014; 127:222.</a></li><li><a class="nounderline abstract_t">Ozturk C, Ganiyusufoglu K, Alanay A, et al. Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery. Spine (Phila Pa 1976) 2010; 35:1893.</a></li><li><a class="nounderline abstract_t">Knudson MM, Ikossi DG, Khaw L, et al. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 2004; 240:490.</a></li><li><a class="nounderline abstract_t">Spencer FA, Bates SM, Goldberg RJ, et al. A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med 2010; 170:1456.</a></li><li><a class="nounderline abstract_t">Moore PS, Andrews JS, Craven TE, et al. Trends in vena caval interruption. J Vasc Surg 2010; 52:118.</a></li><li><a class="nounderline abstract_t">Duszak R Jr, Parker L, Levin DC, Rao VM. Placement and removal of inferior vena cava filters: national trends in the medicare population. J Am Coll Radiol 2011; 8:483.</a></li><li><a class="nounderline abstract_t">Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 2011; 124:655.</a></li><li><a class="nounderline abstract_t">Haut ER, Garcia LJ, Shihab HM, et al. The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. JAMA Surg 2014; 149:194.</a></li><li><a class="nounderline abstract_t">Reddy S, Lakhter V, Zack CJ, et al. Association Between Contemporary Trends in Inferior Vena Cava Filter Placement and the 2010 US Food and Drug Administration Advisory. JAMA Intern Med 2017; 177:1373.</a></li><li><a class="nounderline abstract_t">Pickham DM, Callcut RA, Maggio PM, et al. Payer status is associated with the use of prophylactic inferior vena cava filter in high-risk trauma patients. Surgery 2012; 152:232.</a></li><li class="breakAll">http://wayback.archive-it.org/7993/20170722215731/https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm (Accessed on September 07, 2017).</li><li><a class="nounderline abstract_t">Cook AD, Gross BW, Osler TM, et al. Vena Cava Filter Use in Trauma and Rates of Pulmonary Embolism, 2003-2015. JAMA Surg 2017; 152:724.</a></li><li><a class="nounderline abstract_t">Martin MJ, Blair KS, Curry TK, Singh N. Vena cava filters: current concepts and controversies for the surgeon. Curr Probl Surg 2010; 47:524.</a></li><li><a class="nounderline abstract_t">Stavropoulos SW, Sing RF, Elmasri F, et al. The DENALI Trial: an interim analysis of a prospective, multicenter study of the Denali retrievable inferior vena cava filter. J Vasc Interv Radiol 2014; 25:1497.</a></li><li><a class="nounderline abstract_t">Pais SO, Tobin KD, Austin CB, Queral L. Percutaneous insertion of the Greenfield inferior vena cava filter: experience with ninety-six patients. J Vasc Surg 1988; 8:460.</a></li><li><a class="nounderline abstract_t">Eifler AC, Lewandowski RJ, Gupta R, et al. Optional or permanent: clinical factors that optimize inferior vena cava filter utilization. J Vasc Interv Radiol 2013; 24:35.</a></li><li><a class="nounderline abstract_t">Gillespie DL, Spies JB, Siami FS, et al. Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Study: Design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice. J Vasc Surg Venous Lymphat Disord 2020; 8:187.</a></li><li><a class="nounderline abstract_t">Van Ha TG, Dillon P, Funaki B, et al. Use of retrievable filters in alternative common iliac vein location in high-risk surgical patients. J Vasc Interv Radiol 2011; 22:325.</a></li><li><a class="nounderline abstract_t">Morales JP, Li X, Irony TZ, et al. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord 2013; 1:376.</a></li><li><a class="nounderline abstract_t">Matusov Y, Weinberg AS, Liang R, et al. Use of the Bedside-Placed Angel Catheter IVC Filter for Venous Thromboembolic Disease in Critically Ill Medical Patients. J Intensive Care Med 2020; 35:225.</a></li><li><a class="nounderline abstract_t">Taccone FS, Bunker N, Waldmann C, et al. A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry. J Trauma Acute Care Surg 2015; 79:456.</a></li><li><a class="nounderline abstract_t">Cadavid CA, Gil B, Restrepo A, et al. Pilot study evaluating the safety of a combined central venous catheter and inferior vena cava filter in critically ill patients at high risk of pulmonary embolism. J Vasc Interv Radiol 2013; 24:581.</a></li><li><a class="nounderline abstract_t">Serednicki W, Dobrowolska E, Kałuża K, et al. Angel(®) Catheter use for pulmonary embolism prophylaxis in a polytrauma patient. Injury 2015; 46:1167.</a></li><li><a class="nounderline abstract_t">Spangler EL, Dillavou ED, Smith KJ. Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients. J Vasc Surg 2010; 52:1537.</a></li><li><a class="nounderline abstract_t">Matthews BD, Joels CS, LeQuire MH. Inferior vena cava filter placement: preinsertion inferior vena cava imaging. Am Surg 2003; 69:649.</a></li><li><a class="nounderline abstract_t">Bass JE, Redwine MD, Kramer LA, et al. Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings. Radiographics 2000; 20:639.</a></li><li><a class="nounderline abstract_t">Nam JK, Park SW, Lee SD, Chung MK. The clinical significance of a retroaortic left renal vein. Korean J Urol 2010; 51:276.</a></li><li><a class="nounderline abstract_t">Hislop S, Fanciullo D, Doyle A, et al. Correlation of intravascular ultrasound and computed tomography scan measurements for placement of intravascular ultrasound-guided inferior vena cava filters. J Vasc Surg 2014; 59:1066.</a></li><li><a class="nounderline abstract_t">Glocker RJ, Awonuga O, Novak Z, et al. Bedside inferior vena cava filter placement by intravascular ultrasound in critically ill patients is safe and effective for an extended time. J Vasc Surg Venous Lymphat Disord 2014; 2:377.</a></li><li><a class="nounderline abstract_t">Hodgkiss-Harlow K, Back MR, Brumberg R, et al. Technical factors affecting the accuracy of bedside IVC filter placement using intravascular ultrasound. Vasc Endovascular Surg 2012; 46:293.</a></li><li><a class="nounderline abstract_t">Haley M, Christmas B, Sing RF. Bedside insertion of inferior vena cava filters by a medical intensivist: preliminary results. J Intensive Care Med 2009; 24:144.</a></li><li><a class="nounderline abstract_t">Kardys CM, Stoner MC, Manwaring ML, et al. The use of intravascular ultrasound imaging to improve use of inferior vena cava filters in a high-risk bariatric population. J Vasc Surg 2007; 46:1248.</a></li><li><a class="nounderline abstract_t">Chiou AC. Intravascular ultrasound-guided bedside placement of inferior vena cava filters. Semin Vasc Surg 2006; 19:150.</a></li><li><a class="nounderline abstract_t">Uppal B, Flinn WR, Benjamin ME. The bedside insertion of inferior vena cava filters using ultrasound guidance. Perspect Vasc Surg Endovasc Ther 2007; 19:78.</a></li><li><a class="nounderline abstract_t">Killingsworth CD, Taylor SM, Patterson MA, et al. Prospective implementation of an algorithm for bedside intravascular ultrasound-guided filter placement in critically ill patients. J Vasc Surg 2010; 51:1215.</a></li><li><a class="nounderline abstract_t">Kassavin DS, Constantinopoulos G. The transition to IVUS-guided IVC filter deployment in the nontrauma patient. Vasc Endovascular Surg 2011; 45:142.</a></li><li><a class="nounderline abstract_t">Gill G, Morita S, Kitanosono T, et al. Incidence and complications of accidental cannulation of retroperitoneal veins during venography for inferior vena cava filter placement. Ann Vasc Surg 2013; 27:767.</a></li><li><a class="nounderline abstract_t">Abdel-Aal AK, Saddekni S, Hamed MF. Guide wire entrapment in a vena cava filter: techniques for dislodgement. Vasc Endovascular Surg 2013; 47:115.</a></li><li><a class="nounderline abstract_t">Fang AS, Morita S, Gill GS, et al. Clinical outcomes of inferior vena cava filter placement in patients with renal vein anomalies. Ann Vasc Surg 2014; 28:318.</a></li><li><a class="nounderline abstract_t">Baheti A, Sheeran D, Patrie J, et al. Suprarenal Inferior Vena Cava Filter Placement and Retrieval: Safety Analysis. J Vasc Interv Radiol 2020; 31:231.</a></li><li><a class="nounderline abstract_t">Harris SA, Velineni R, Davies AH. Inferior Vena Cava Filters in Pregnancy: A Systematic Review. J Vasc Interv Radiol 2016; 27:354.</a></li><li><a class="nounderline abstract_t">Ascer E, Gennaro M, Lorensen E, Pollina RM. Superior vena caval Greenfield filters: indications, techniques, and results. J Vasc Surg 1996; 23:498.</a></li><li><a class="nounderline abstract_t">Ascher E, Hingorani A, Tsemekhin B, et al. Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters. J Vasc Surg 2000; 32:881.</a></li><li><a class="nounderline abstract_t">Watanabe S, Shimokawa S, Shibuya H, et al. Superior vena caval placement of a temporary filter: a case report. Vasc Surg 2001; 35:59.</a></li><li><a class="nounderline abstract_t">Usoh F, Hingorani A, Ascher E, et al. Long-term follow-up for superior vena cava filter placement. Ann Vasc Surg 2009; 23:350.</a></li><li><a class="nounderline abstract_t">Mismetti P, Rivron-Guillot K, Quenet S, et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest 2007; 131:223.</a></li><li><a class="nounderline abstract_t">Stein PD, Alnas M, Skaf E, et al. Outcome and complications of retrievable inferior vena cava filters. Am J Cardiol 2004; 94:1090.</a></li><li><a class="nounderline abstract_t">Lynch FC. Removal of a Günther Tulip filter after 3,006 days. J Vasc Interv Radiol 2011; 22:337.</a></li><li><a class="nounderline abstract_t">Garcia-Godoy F, Collins T, Sacks D, et al. Retrieval of inferior vena cava filters after prolonged indwelling time. Arch Intern Med 2011; 171:1953.</a></li><li><a class="nounderline abstract_t">Naidu SG, Stone WM, Sweeney JP, Money SR. Endovascular retrieval of a TrapEase permanent inferior vena cava filter from the aorta. J Vasc Surg 2012; 55:237.</a></li><li><a class="nounderline abstract_t">Angel LF, Tapson V, Galgon RE, et al. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol 2011; 22:1522.</a></li><li><a class="nounderline abstract_t">Helling TS, Kaswan S, Miller SL, Tretter JF. Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: a single-center experience. J Trauma 2009; 67:1293.</a></li><li><a class="nounderline abstract_t">Sarosiek S, Crowther M, Sloan JM. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med 2013; 173:513.</a></li><li><a class="nounderline abstract_t">Al-Hakim R, Kee ST, Olinger K, et al. Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques. J Vasc Interv Radiol 2014; 25:933.</a></li><li><a class="nounderline abstract_t">Gyang E, Zayed M, Harris EJ, et al. Factors impacting follow-up care after placement of temporary inferior vena cava filters. J Vasc Surg 2013; 58:440.</a></li><li><a class="nounderline abstract_t">Lynch FC. A method for following patients with retrievable inferior vena cava filters: results and lessons learned from the first 1,100 patients. J Vasc Interv Radiol 2011; 22:1507.</a></li><li><a class="nounderline abstract_t">Abtahian F, Hawkins BM, Ryan DP, et al. Inferior vena cava filter usage, complications, and retrieval rate in cancer patients. Am J Med 2014; 127:1111.</a></li><li><a class="nounderline abstract_t">Siracuse JJ, Al Bazroon A, Gill HL, et al. Risk factors of nonretrieval of retrievable inferior vena cava filters. Ann Vasc Surg 2015; 29:318.</a></li><li><a class="nounderline abstract_t">Albrecht RM, Garwe T, Carter SM, Maurer AJ. Retrievable inferior vena cava filters in trauma patients: factors that influence removal rate and an argument for institutional protocols. Am J Surg 2012; 203:297.</a></li><li><a class="nounderline abstract_t">Irwin E, Byrnes M, Schultz S, et al. A systematic method for follow-up improves removal rates for retrievable inferior vena cava filters in a trauma patient population. J Trauma 2010; 69:866.</a></li><li><a class="nounderline abstract_t">Minocha J, Idakoji I, Riaz A, et al. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol 2010; 21:1847.</a></li><li><a class="nounderline abstract_t">Rogers FB, Shackford SR, Miller JA, et al. Improved recovery of prophylactic inferior vena cava filters in trauma patients: the results of a dedicated filter registry and critical pathway for filter removal. J Trauma Acute Care Surg 2012; 72:381.</a></li><li><a class="nounderline abstract_t">Sutphin PD, Reis SP, McKune A, et al. Improving inferior vena cava filter retrieval rates with the define, measure, analyze, improve, control methodology. J Vasc Interv Radiol 2015; 26:491.</a></li><li><a class="nounderline abstract_t">Tao MJ, Montbriand JM, Eisenberg N, et al. Temporary inferior vena cava filter indications, retrieval rates, and follow-up management at a multicenter tertiary care institution. J Vasc Surg 2016; 64:430.</a></li><li><a class="nounderline abstract_t">Wang SL, Cha HH, Lin JR, et al. Impact of Physician Education and a Dedicated Inferior Vena Cava Filter Tracking System on Inferior Vena Cava Filter Use and Retrieval Rates Across a Large US Health Care Region. J Vasc Interv Radiol 2016; 27:740.</a></li><li><a class="nounderline abstract_t">Charlton-Ouw KM, Leake SS, Sola CN, et al. Technical and financial feasibility of an inferior vena cava filter retrieval program at a level one trauma center. Ann Vasc Surg 2015; 29:84.</a></li><li><a class="nounderline abstract_t">Given MF, McDonald BC, Brookfield P, et al. Retrievable Gunther Tulip inferior vena cava filter: experience in 317 patients. J Med Imaging Radiat Oncol 2008; 52:452.</a></li><li><a class="nounderline abstract_t">Cantwell CP, Pennypacker J, Singh H, et al. Comparison of the recovery and G2 filter as retrievable inferior vena cava filters. J Vasc Interv Radiol 2009; 20:1193.</a></li><li><a class="nounderline abstract_t">Johnson MS, Nemcek AA Jr, Benenati JF, et al. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study. J Vasc Interv Radiol 2010; 21:1173.</a></li><li><a class="nounderline abstract_t">Lyon SM, Riojas GE, Uberoi R, et al. Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol 2009; 20:1441.</a></li><li><a class="nounderline abstract_t">Hiromatsu S, Nata S, Ohno T, et al. Non-permanent inferior vena cava filters for prophylaxis and treatment of lower limb venous thromboembolism. Vasc Endovascular Surg 2010; 44:668.</a></li><li><a class="nounderline abstract_t">Zhu X, Tam MD, Bartholomew J, et al. Retrievability and device-related complications of the G2 filter: a retrospective study of 139 filter retrievals. J Vasc Interv Radiol 2011; 22:806.</a></li><li><a class="nounderline abstract_t">Shukla PA, Nwoke F, Menon S, Halpert E. Dual access snare-over-wire method for retrieval of option inferior vena cava filters. J Vasc Interv Radiol 2014; 25:1652.</a></li><li><a class="nounderline abstract_t">Cho E, Lim KJ, Jo JH, et al. Failed inferior vena cava filter retrieval by conventional method: Analysis of its causes and retrieval of it by modified double-loop technique. Phlebology 2015; 30:549.</a></li><li><a class="nounderline abstract_t">Stavropoulos SW, Ge BH, Mondschein JI, et al. Retrieval of Tip-embedded Inferior Vena Cava Filters by Using the Endobronchial Forceps Technique: Experience at a Single Institution. Radiology 2015; 275:900.</a></li><li><a class="nounderline abstract_t">Teo TK, Angle JF, Shipp JI, et al. Incidence and management of inferior vena cava filter thrombus detected at time of filter retrieval. J Vasc Interv Radiol 2011; 22:1514.</a></li><li><a class="nounderline abstract_t">Al-Hakim R, McWilliams JP, Derry W, Kee ST. The hangman technique: a modified loop snare technique for the retrieval of inferior vena cava filters with embedded hooks. J Vasc Interv Radiol 2015; 26:107.</a></li><li><a class="nounderline abstract_t">Janne d'Othée B. Predicting the removal of optionally retrievable caval filters: are we there yet? J Vasc Interv Radiol 2013; 24:40.</a></li><li><a class="nounderline abstract_t">Avgerinos ED, Bath J, Stevens J, et al. Technical and patient-related characteristics associated with challenging retrieval of inferior vena cava filters. Eur J Vasc Endovasc Surg 2013; 46:353.</a></li><li><a class="nounderline abstract_t">Millward SF, Oliva VL, Bell SD, et al. Günther Tulip Retrievable Vena Cava Filter: results from the Registry of the Canadian Interventional Radiology Association. J Vasc Interv Radiol 2001; 12:1053.</a></li><li><a class="nounderline abstract_t">Lorch H, Welger D, Wagner V, et al. Current practice of temporary vena cava filter insertion: a multicenter registry. J Vasc Interv Radiol 2000; 11:83.</a></li><li><a class="nounderline abstract_t">Imberti D, Bianchi M, Farina A, et al. Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study. J Thromb Haemost 2005; 3:1370.</a></li><li><a class="nounderline abstract_t">Foley PJ, Nathan DP, Wang GJ, et al. A "fall-back" technique for difficult inferior vena cava filter retrieval. J Vasc Surg 2012; 56:1629.</a></li><li><a class="nounderline abstract_t">Dinglasan LA, Oh JC, Schmitt JE, et al. Complicated inferior vena cava filter retrievals: associated factors identified at preretrieval CT. Radiology 2013; 266:347.</a></li><li><a class="nounderline abstract_t">Zhou D, Spain J, Moon E, et al. Retrospective review of 120 celect inferior vena cava filter retrievals: experience at a single institution. J Vasc Interv Radiol 2012; 23:1557.</a></li><li><a class="nounderline abstract_t">Kuo WT, Odegaard JI, Rosenberg JK, Hofmann LV. Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study. Circ Cardiovasc Interv 2013; 6:560.</a></li><li><a class="nounderline abstract_t">Mahmood SS, Abtahian F, Fogerty AE, et al. Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma. Am J Med 2017; 130:77.</a></li><li><a class="nounderline abstract_t">Joels CS, Sing RF, Heniford BT. Complications of inferior vena cava filters. Am Surg 2003; 69:654.</a></li><li><a class="nounderline abstract_t">Nazzal M, Chan E, Nazzal M, et al. Complications related to inferior vena cava filters: a single-center experience. Ann Vasc Surg 2010; 24:480.</a></li><li><a class="nounderline abstract_t">Jia Z, Wu A, Tam M, et al. Caval Penetration by Inferior Vena Cava Filters: A Systematic Literature Review of Clinical Significance and Management. Circulation 2015; 132:944.</a></li><li class="breakAll">https://clinicaltrials.gov/ct2/show/NCT02381509?term=preserve+ivc+filter&amp;rank=1 (Accessed on December 05, 2016).</li><li><a class="nounderline abstract_t">Andreoli JM, Lewandowski RJ, Vogelzang RL, Ryu RK. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol 2014; 25:1181.</a></li><li><a class="nounderline abstract_t">Lambe BD, Bedway JJ, Friedell ML. Percutaneous femoral vein access for inferior vena cava filter placement does not cause insertion-site thrombosis. Ann Vasc Surg 2013; 27:1169.</a></li><li><a class="nounderline abstract_t">Gorman PH, Qadri SF, Rao-Patel A. Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury. J Trauma 2009; 66:707.</a></li><li><a class="nounderline abstract_t">Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338:409.</a></li><li><a class="nounderline abstract_t">PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112:416.</a></li><li><a class="nounderline abstract_t">Blebea J, Wilson R, Waybill P, et al. Deep venous thrombosis after percutaneous insertion of vena caval filters. J Vasc Surg 1999; 30:821.</a></li><li><a class="nounderline abstract_t">Streiff MB. Vena caval filters: a comprehensive review. Blood 2000; 95:3669.</a></li><li><a class="nounderline abstract_t">Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 1992; 152:1985.</a></li><li><a class="nounderline abstract_t">Girard P, Stern JB, Parent F. Medical literature and vena cava filters: so far so weak. Chest 2002; 122:963.</a></li><li><a class="nounderline abstract_t">White RH, Brunson A, Romano PS, et al. Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study. Circulation 2016; 133:2018.</a></li><li><a class="nounderline abstract_t">Usoh F, Hingorani A, Ascher E, et al. Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters. J Vasc Surg 2010; 52:394.</a></li><li><a class="nounderline abstract_t">Hajduk B, Tomkowski WZ, Malek G, Davidson BL. Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest 2010; 137:877.</a></li><li><a class="nounderline abstract_t">McAree BJ, O'Donnell ME, Fitzmaurice GJ, et al. Inferior vena cava thrombosis: a review of current practice. Vasc Med 2013; 18:32.</a></li><li><a class="nounderline abstract_t">Pan Y, Zhao J, Mei J, et al. Retrievable Inferior Vena Cava Filters in Trauma Patients: Prevalence and Management of Thrombus Within the Filter. Eur J Vasc Endovasc Surg 2016; 52:830.</a></li><li><a class="nounderline abstract_t">Raju S, Hollis K, Neglen P. Obstructive lesions of the inferior vena cava: clinical features and endovenous treatment. J Vasc Surg 2006; 44:820.</a></li><li><a class="nounderline abstract_t">Ye K, Lu X, Li W, et al. Outcomes of Stent Placement for Chronic Occlusion of a Filter-bearing Inferior Vena Cava in Patients with Severe Post-thrombotic Syndrome. Eur J Vasc Endovasc Surg 2016; 52:839.</a></li><li><a class="nounderline abstract_t">Stein PD, Matta F, Keyes DC, Willyerd GL. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism. Am J Med 2012; 125:478.</a></li><li><a class="nounderline abstract_t">Ku GH, Billett HH. Long lives, short indications. The case for removable inferior cava filters. Thromb Haemost 2005; 93:17.</a></li><li><a class="nounderline abstract_t">Stavropoulos SW, Chen JX, Sing RF, et al. Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter. J Vasc Interv Radiol 2016; 27:1531.</a></li><li><a class="nounderline abstract_t">Branco BC, Montero-Baker MF, Espinoza E, et al. Pharmacomechanical thrombolysis in the management of acute inferior vena cava filter occlusion using the Trellis-8 device. J Endovasc Ther 2015; 22:99.</a></li><li><a class="nounderline abstract_t">Mismetti P, Laporte S, Pellerin O, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA 2015; 313:1627.</a></li><li><a class="nounderline abstract_t">Vena Caval Filter Consensus Conference. Recommended reporting standards for vena caval filter placement and patient follow-up. J Vasc Interv Radiol 2003; 14:S427.</a></li><li><a class="nounderline abstract_t">Ferris EJ, McCowan TC, Carver DK, McFarland DR. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology 1993; 188:851.</a></li><li><a class="nounderline abstract_t">Wu A, Helo N, Moon E, et al. Strategies for prevention of iatrogenic inferior vena cava filter entrapment and dislodgement during central venous catheter placement. J Vasc Surg 2014; 59:255.</a></li><li><a class="nounderline abstract_t">Duong MH, Jensen WA, Kirsch CM, et al. An unusual complication during central venous catheter placement. J Clin Anesth 2001; 13:131.</a></li><li><a class="nounderline abstract_t">Vinces FY, Robb TV, Alapati K, et al. J-tip spring guidewire entrapment by an inferior vena cava filter. J Am Osteopath Assoc 2004; 104:87.</a></li><li><a class="nounderline abstract_t">Wholey M, Toursarkissian B, Velez G, et al. Technique for retrieval of a guidewire lodged in a vena cava filter. Vasc Endovascular Surg 2002; 36:385.</a></li><li><a class="nounderline abstract_t">Stavropoulos SW, Itkin M, Trerotola SO. In vitro study of guide wire entrapment in currently available inferior vena cava filters. J Vasc Interv Radiol 2003; 14:905.</a></li><li><a class="nounderline abstract_t">Almestady R, Spain J, Bayona-Molano Mdel P, Wang W. Iatrogenic migration of VenaTech LP IVC filter to superior vena cava secondary to guidewire entrapment: case report and review of literature. Vasc Endovascular Surg 2013; 47:48.</a></li><li><a class="nounderline abstract_t">Porcellini M, Stassano P, Musumeci A, Bracale G. Intracardiac migration of nitinol TrapEase vena cava filter and paradoxical embolism. Eur J Cardiothorac Surg 2002; 22:460.</a></li><li><a class="nounderline abstract_t">Arjomand H, Surabhi S, Wolf NM. Right ventricular foreign body: percutaneous transvenous retrieval of a Greenfield filter from the right ventricle--a case report. Angiology 2003; 54:109.</a></li><li><a class="nounderline abstract_t">Bochenek KM, Aruny JE, Tal MG. Right atrial migration and percutaneous retrieval of a Günther Tulip inferior vena cava filter. J Vasc Interv Radiol 2003; 14:1207.</a></li><li><a class="nounderline abstract_t">Yegul TN, Bonilla SM, Goodwin SC, et al. Retrieval of a Greenfield IVC filter displaced to the right brachiocephalic vein. Cardiovasc Intervent Radiol 2000; 23:403.</a></li><li><a class="nounderline abstract_t">Joe WB, Larson ML, Madassery S, et al. Bowel Penetration by Inferior Vena Cava Filters: Feasibility and Safety of Percutaneous Retrieval. AJR Am J Roentgenol 2019; 213:1152.</a></li><li><a class="nounderline abstract_t">Caldwell EH, Fridley TL, Erb EL, Fleischer SR. Endovascular retrieval of an inferior vena cava filter with simultaneous caval, aortic, and duodenal perforations. Vasc Endovascular Surg 2012; 46:671.</a></li><li><a class="nounderline abstract_t">Zhou D, Moon E, Bullen J, et al. Penetration of Celect inferior vena cava filters: retrospective review of CT scans in 265 patients. AJR Am J Roentgenol 2014; 202:643.</a></li><li><a class="nounderline abstract_t">Malek JY, Kwolek CJ, Conrad MF, et al. Presentation and treatment outcomes of patients with symptomatic inferior vena cava filters. Ann Vasc Surg 2013; 27:84.</a></li><li><a class="nounderline abstract_t">Yoshida Rde A, Yoshida WB, Kolvenbach R, Vieira PR. Endovascular treatment of late aortic perforation due to vena cava filter. Ann Vasc Surg 2012; 26:859.e9.</a></li><li><a class="nounderline abstract_t">Malgor RD, Hines GL, Terrana L, Labropoulos N. Persistent abdominal pain caused by an inferior vena cava filter protruding into the duodenum and the aortic wall. Ann Vasc Surg 2012; 26:858.e3.</a></li><li><a class="nounderline abstract_t">Skeik N, McEachen JC, Stockland AH, et al. Lumbar artery pseudoaneurysm caused by a Gunther Tulip inferior vena cava filter. Vasc Endovascular Surg 2011; 45:756.</a></li><li><a class="nounderline abstract_t">Connolly PH, Balachandran VP, Trost D, Bush HL Jr. Open surgical inferior vena cava filter retrieval for caval perforation and a novel technique for minimal cavotomy filter extraction. J Vasc Surg 2012; 56:256.</a></li><li><a class="nounderline abstract_t">Rasuli P. Inferior vena cava penetration by günther tulip filter? J Vasc Interv Radiol 2013; 24:752.</a></li><li><a class="nounderline abstract_t">McLoney ED, Krishnasamy VP, Castle JC, et al. Complications of Celect, Günther tulip, and Greenfield inferior vena cava filters on CT follow-up: a single-institution experience. J Vasc Interv Radiol 2013; 24:1723.</a></li><li><a class="nounderline abstract_t">Yeung LY, Hastings GS, Alexander JQ. Endovascular retrieval of inferior vena cava filter penetrating into aorta: an unusual presentation of abdominal pain. Vasc Endovascular Surg 2010; 44:683.</a></li><li><a class="nounderline abstract_t">Becher RD, Corriere MA, Edwards MS, Godshall CJ. Late erosion of a prophylactic Celect IVC filter into the aorta, right renal artery, and duodenal wall. J Vasc Surg 2010; 52:1041.</a></li><li><a class="nounderline abstract_t">Sparrow P. Double whammy: inferior vena cava filter-related perforation and thrombosis of the inferior vena cava and aorta. Circulation 2011; 123:e245.</a></li><li><a class="nounderline abstract_t">Olorunsola OG, Kohi MP, Fidelman N, et al. Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and Günther Tulip filters. J Vasc Interv Radiol 2013; 24:566.</a></li><li><a class="nounderline abstract_t">Wood EA, Malgor RD, Gasparis AP, Labropoulos N. Reporting the impact of inferior vena cava perforation by filters. Phlebology 2014; 29:471.</a></li><li><a class="nounderline abstract_t">Venturini M, Civilini E, Orsi M, et al. Successful endovascular retrieval of an ALN inferior vena cava filter causing asymptomatic aortic dissection, perforation of the cava wall and duodenum. J Vasc Interv Radiol 2015; 26:608.</a></li><li><a class="nounderline abstract_t">Pontone G, Andreini D, Bertella E, et al. Asymptomatic struts fracture and multiple embolization as a late complication of ALN removable vena cava filter implantation. Eur Heart J 2013; 34:2353.</a></li><li><a class="nounderline abstract_t">Rogers NA, Nguyen L, Minniefield NE, et al. Fracture and embolization of an inferior vena cava filter strut leading to cardiac tamponade. Circulation 2009; 119:2535.</a></li><li><a class="nounderline abstract_t">Nicholson W, Nicholson WJ, Tolerico P, et al. Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade. Arch Intern Med 2010; 170:1827.</a></li><li><a class="nounderline abstract_t">Tam MD, Spain J, Lieber M, et al. Fracture and distant migration of the Bard Recovery filter: a retrospective review of 363 implantations for potentially life-threatening complications. J Vasc Interv Radiol 2012; 23:199.</a></li><li><a class="nounderline abstract_t">Johnson MS. Vena cava filter fracture: unplanned obsolescence. J Vasc Interv Radiol 2012; 23:196.</a></li><li><a class="nounderline abstract_t">Dinglasan LA, Trerotola SO, Shlansky-Goldberg RD, et al. Removal of fractured inferior vena cava filters: feasibility and outcomes. J Vasc Interv Radiol 2012; 23:181.</a></li><li><a class="nounderline abstract_t">Vijay K, Hughes JA, Burdette AS, et al. Fractured Bard Recovery, G2, and G2 express inferior vena cava filters: incidence, clinical consequences, and outcomes of removal attempts. J Vasc Interv Radiol 2012; 23:188.</a></li><li><a class="nounderline abstract_t">An T, Moon E, Bullen J, et al. Prevalence and clinical consequences of fracture and fragment migration of the Bard G2 filter: imaging and clinical follow-up in 684 implantations. J Vasc Interv Radiol 2014; 25:941.</a></li><li><a class="nounderline abstract_t">Nguyen NT, Barshes NR, Bechara CF, Pisimisis GT. Natural history of an intra-aortic permanent inferior vena cava filter. J Vasc Surg 2014; 60:784.</a></li><li><a class="nounderline abstract_t">Trerotola SO, Stavropoulos SW. Management of Fractured Inferior Vena Cava Filters: Outcomes by Fragment Location. Radiology 2017; 284:887.</a></li><li><a class="nounderline abstract_t">Athanasoulis CA, Kaufman JA, Halpern EF, et al. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000; 216:54.</a></li><li><a class="nounderline abstract_t">Chow FC, Chan YC, Cheung GC, Cheng SW. Mid- and long-term outcome of patients with permanent inferior vena cava filters: a single center review. Ann Vasc Surg 2015; 29:985.</a></li></ol></div><div id="topicVersionRevision">Topic 8212 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22156155" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Review of indications and practices of vena caval filters at a large university hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22698970" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Indications for inferior vena cava filter placement: do physicians comply with guidelines?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23552572" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : High variation between hospitals in vena cava filter use for venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23305597" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical, demographic, and medicolegal factors associated with geographic variation in inferior vena cava filter utilization: an interstate analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23700187" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Hospital-specific risk factors for filter fever.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26366537" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prophylactic Inferior Vena Cava Filter Placement Does Not Result in a Survival Benefit for Trauma Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34352278" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26867832" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315268" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32919823" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Society of Interventional Radiology Clinical Practice Guideline for Inferior Vena Cava Filters in the Treatment of Patients with Venous Thromboembolic Disease: Developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on Trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22315263" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646021" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30646019" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24280176" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Vena cava filters in unstable elderly patients with acute pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20802386" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15319720" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20837832" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A population-based study of inferior vena cava filters in patients with acute venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20304583" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Trends in vena caval interruption.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21723485" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Placement and removal of inferior vena cava filters: national trends in the medicare population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21592452" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Increasing use of vena cava filters for prevention of pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24195920" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28692712" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association Between Contemporary Trends in Inferior Vena Cava Filter Placement and the 2010 US Food and Drug Administration Advisory.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22828145" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Payer status is associated with the use of prophylactic inferior vena cava filter in high-risk trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22828145" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Payer status is associated with the use of prophylactic inferior vena cava filter in high-risk trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28492861" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Vena Cava Filter Use in Trauma and Rates of Pulmonary Embolism, 2003-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20682152" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Vena cava filters: current concepts and controversies for the surgeon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25066514" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The DENALI Trial: an interim analysis of a prospective, multicenter study of the Denali retrievable inferior vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3172383" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Percutaneous insertion of the Greenfield inferior vena cava filter: experience with ninety-six patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23176967" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Optional or permanent: clinical factors that optimize inferior vena cava filter utilization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31636051" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Study: Design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21277796" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Use of retrievable filters in alternative common iliac vein location in high-risk surgical patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26992759" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31994987" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Use of the Bedside-Placed Angel Catheter IVC Filter for Venous Thromboembolic Disease in Critically Ill Medical Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26307880" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A new device for the prevention of pulmonary embolism in critically ill patients: Results of the European Angel Catheter Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23522160" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pilot study evaluating the safety of a combined central venous catheter and inferior vena cava filter in critically ill patients at high risk of pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25890862" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Angel(®) Catheter use for pulmonary embolism prophylaxis in a polytrauma patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20843631" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12953820" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Inferior vena cava filter placement: preinsertion inferior vena cava imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10835118" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Spectrum of congenital anomalies of the inferior vena cava: cross-sectional imaging findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20428432" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The clinical significance of a retroaortic left renal vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24388045" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Correlation of intravascular ultrasound and computed tomography scan measurements for placement of intravascular ultrasound-guided inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26993541" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Bedside inferior vena cava filter placement by intravascular ultrasound in critically ill patients is safe and effective for an extended time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22544870" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Technical factors affecting the accuracy of bedside IVC filter placement using intravascular ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19188271" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Bedside insertion of inferior vena cava filters by a medical intensivist: preliminary results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17920228" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : The use of intravascular ultrasound imaging to improve use of inferior vena cava filters in a high-risk bariatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16996417" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Intravascular ultrasound-guided bedside placement of inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17437987" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The bedside insertion of inferior vena cava filters using ultrasound guidance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20223628" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Prospective implementation of an algorithm for bedside intravascular ultrasound-guided filter placement in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21278179" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The transition to IVUS-guided IVC filter deployment in the nontrauma patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23711967" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Incidence and complications of accidental cannulation of retroperitoneal veins during venography for inferior vena cava filter placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23275482" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Guide wire entrapment in a vena cava filter: techniques for dislodgement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24084271" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Clinical outcomes of inferior vena cava filter placement in patients with renal vein anomalies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31883935" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Suprarenal Inferior Vena Cava Filter Placement and Retrieval: Safety Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26746328" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Inferior Vena Cava Filters in Pregnancy: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8601894" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Superior vena caval Greenfield filters: indications, techniques, and results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11054219" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668370" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Superior vena caval placement of a temporary filter: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18809292" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Long-term follow-up for superior vena cava filter placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17218580" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15476636" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Outcome and complications of retrievable inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21277802" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Removal of a Günther Tulip filter after 3,006 days.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22123810" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Retrieval of inferior vena cava filters after prolonged indwelling time.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21820840" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Endovascular retrieval of a TrapEase permanent inferior vena cava filter from the aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22024114" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Systematic review of the use of retrievable inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20009680" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23552968" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24630748" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Inferior vena cava filter retrieval: effectiveness and complications of routine and advanced techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23588109" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Factors impacting follow-up care after placement of temporary inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21903414" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : A method for following patients with retrievable inferior vena cava filters: results and lessons learned from the first 1,100 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24997415" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Inferior vena cava filter usage, complications, and retrieval rate in cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25308241" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Risk factors of nonretrieval of retrievable inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22192615" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Retrievable inferior vena cava filters in trauma patients: factors that influence removal rate and an argument for institutional protocols.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20938273" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : A systematic method for follow-up improves removal rates for retrievable inferior vena cava filters in a trauma patient population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21035356" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22327980" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Improved recovery of prophylactic inferior vena cava filters in trauma patients: the results of a dedicated filter registry and critical pathway for filter removal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25636673" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Improving inferior vena cava filter retrieval rates with the define, measure, analyze, improve, control methodology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27038836" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Temporary inferior vena cava filter indications, retrieval rates, and follow-up management at a multicenter tertiary care institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27017122" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Impact of Physician Education and a Dedicated Inferior Vena Cava Filter Tracking System on Inferior Vena Cava Filter Use and Retrieval Rates Across a Large US Health Care Region.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24930980" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Technical and financial feasibility of an inferior vena cava filter retrieval program at a level one trauma center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19032390" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Retrievable Gunther Tulip inferior vena cava filter: experience in 317 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19640733" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Comparison of the recovery and G2 filter as retrievable inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20598570" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19875061" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724287" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Non-permanent inferior vena cava filters for prophylaxis and treatment of lower limb venous thromboembolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21482140" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Retrievability and device-related complications of the G2 filter: a retrospective study of 139 filter retrievals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25255954" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Dual access snare-over-wire method for retrieval of option inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25096757" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Failed inferior vena cava filter retrieval by conventional method: Analysis of its causes and retrieval of it by modified double-loop technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25581368" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Retrieval of Tip-embedded Inferior Vena Cava Filters by Using the Endobronchial Forceps Technique: Experience at a Single Institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21937242" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Incidence and management of inferior vena cava filter thrombus detected at time of filter retrieval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25541448" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : The hangman technique: a modified loop snare technique for the retrieval of inferior vena cava filters with embedded hooks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23273696" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Predicting the removal of optionally retrievable caval filters: are we there yet?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23831140" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Technical and patient-related characteristics associated with challenging retrieval of inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11535767" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Günther Tulip Retrievable Vena Cava Filter: results from the Registry of the Canadian Interventional Radiology Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10693718" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Current practice of temporary vena cava filter insertion: a multicenter registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15978093" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22607712" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : A "fall-back" technique for difficult inferior vena cava filter retrieval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23047840" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Complicated inferior vena cava filter retrievals: associated factors identified at preretrieval CT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23177101" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Retrospective review of 120 celect inferior vena cava filter retrievals: experience at a single institution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24065445" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Excimer laser-assisted removal of embedded inferior vena cava filters: a single-center prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27477669" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12953821" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Complications of inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19900783" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Complications related to inferior vena cava filters: a single-center experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26169756" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Caval Penetration by Inferior Vena Cava Filters: A Systematic Literature Review of Clinical Significance and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26169756" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Caval Penetration by Inferior Vena Cava Filters: A Systematic Literature Review of Clinical Significance and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24928649" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23988547" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Percutaneous femoral vein access for inferior vena cava filter placement does not cause insertion-site thrombosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19276742" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Prophylactic inferior vena cava (IVC) filter placement may increase the relative risk of deep venous thrombosis after acute spinal cord injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9459643" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16009794" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10550179" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Deep venous thrombosis after percutaneous insertion of vena caval filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10845895" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Vena caval filters: a comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1417371" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Inferior vena cava filters. Indications, safety, effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12226040" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Medical literature and vena cava filters: so far so weak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27048765" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Outcomes After Vena Cava Filter Use in Noncancer Patients With Acute Venous Thromboembolism: A Population-Based Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20570472" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Prospective randomized study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19880907" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23439778" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Inferior vena cava thrombosis: a review of current practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27692532" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Retrievable Inferior Vena Cava Filters in Trauma Patients: Prevalence and Management of Thrombus Within the Filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16926084" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Obstructive lesions of the inferior vena cava: clinical features and endovenous treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27751714" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Outcomes of Stent Placement for Chronic Occlusion of a Filter-bearing Inferior Vena Cava in Patients with Severe Post-thrombotic Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22310013" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15630485" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Long lives, short indications. The case for removable inferior cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27569678" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Analysis of the Final DENALI Trial Data: A Prospective, Multicenter Study of the Denali Inferior Vena Cava Filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25775688" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Pharmacomechanical thrombolysis in the management of acute inferior vena cava filter occlusion using the Trellis-8 device.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25919526" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14514858" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Recommended reporting standards for vena caval filter placement and patient follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8351361" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24080132" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Strategies for prevention of iatrogenic inferior vena cava filter entrapment and dislodgement during central venous catheter placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11331175" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : An unusual complication during central venous catheter placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15040421" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : J-tip spring guidewire entrapment by an inferior vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12244428" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Technique for retrieval of a guidewire lodged in a vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12847198" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : In vitro study of guide wire entrapment in currently available inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23203598" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Iatrogenic migration of VenaTech LP IVC filter to superior vena cava secondary to guidewire entrapment: case report and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12204746" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Intracardiac migration of nitinol TrapEase vena cava filter and paradoxical embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12593503" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Right ventricular foreign body: percutaneous transvenous retrieval of a Greenfield filter from the right ventricle--a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14514816" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Right atrial migration and percutaneous retrieval of a Günther Tulip inferior vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11060375" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Retrieval of a Greenfield IVC filter displaced to the right brachiocephalic vein.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31216197" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Bowel Penetration by Inferior Vena Cava Filters: Feasibility and Safety of Percutaneous Retrieval.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23129585" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Endovascular retrieval of an inferior vena cava filter with simultaneous caval, aortic, and duodenal perforations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24555603" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Penetration of Celect inferior vena cava filters: retrospective review of CT scans in 265 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23084735" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Presentation and treatment outcomes of patients with symptomatic inferior vena cava filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22717360" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Endovascular treatment of late aortic perforation due to vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22627053" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Persistent abdominal pain caused by an inferior vena cava filter protruding into the duodenum and the aortic wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22262118" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Lumbar artery pseudoaneurysm caused by a Gunther Tulip inferior vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22503185" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Open surgical inferior vena cava filter retrieval for caval perforation and a novel technique for minimal cavotomy filter extraction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23622047" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Inferior vena cava penetration by günther tulip filter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24041915" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Complications of Celect, Günther tulip, and Greenfield inferior vena cava filters on CT follow-up: a single-institution experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20675325" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Endovascular retrieval of inferior vena cava filter penetrating into aorta: an unusual presentation of abdominal pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20619588" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Late erosion of a prophylactic Celect IVC filter into the aorta, right renal artery, and duodenal wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343589" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Double whammy: inferior vena cava filter-related perforation and thrombosis of the inferior vena cava and aorta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23462065" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Caval penetration by retrievable inferior vena cava filters: a retrospective comparison of Option and Günther Tulip filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23761875" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Reporting the impact of inferior vena cava perforation by filters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25805548" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Successful endovascular retrieval of an ALN inferior vena cava filter causing asymptomatic aortic dissection, perforation of the cava wall and duodenum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23209260" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Asymptomatic struts fracture and multiple embolization as a late complication of ALN removable vena cava filter implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19433771" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Fracture and embolization of an inferior vena cava filter strut leading to cardiac tamponade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20696949" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22188776" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Fracture and distant migration of the Bard Recovery filter: a retrospective review of 363 implantations for potentially life-threatening complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22264552" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Vena cava filter fracture: unplanned obsolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22178038" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Removal of fractured inferior vena cava filters: feasibility and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22173108" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Fractured Bard Recovery, G2, and G2 express inferior vena cava filters: incidence, clinical consequences, and outcomes of removal attempts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24656176" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Prevalence and clinical consequences of fracture and fragment migration of the Bard G2 filter: imaging and clinical follow-up in 684 implantations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25154964" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Natural history of an intra-aortic permanent inferior vena cava filter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28421970" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Management of Fractured Inferior Vena Cava Filters: Outcomes by Fragment Location.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10887228" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Inferior vena caval filters: review of a 26-year single-center clinical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25757994" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Mid- and long-term outcome of patients with permanent inferior vena cava filters: a single center review.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
